Last updated: February 28, 2026
What is the Scope of Patent BR112017010166?
Patent BR112017010166 protects a pharmaceutical invention related to a specific active ingredient formulation or process, likely targeting a therapeutic area such as oncology, infectious diseases, or chronic conditions. The patent was filed in Brazil and granted under the national patent office (INPI).
Based on typical structure, the patent's scope covers:
- A novel composition involving a particular active ingredient or combination.
- A manufacturing process that enhances stability, bioavailability, or efficacy.
- Specific formulations, including dosage forms like tablets or injectables.
- Method of use claims for treatment of a defined medical condition.
The patent's claims aim to prevent third parties from manufacturing, using, or selling similar formulations or processes throughout Brazil for up to 20 years from filing or priority date, whichever is later.
What Are the Detailed Claims of Patent BR112017010166?
The patent includes independent and dependent claims that define the invention’s boundaries. Generally, these claims cover:
Main Claims
- A composition comprising a specific active ingredient (e.g., a novel compound or a known compound with a new formulation).
- The composition's specific form, such as a sustained-release tablet or a lyophilized powder.
- A process for producing the composition, including specific steps or conditions (e.g., a solvent-based process, micronization techniques).
Dependent Claims
- Variations of the main formulation, such as different excipient combinations.
- Specific concentrations or ratios of active ingredients.
- Alternative manufacturing conditions or particular stability enhancements.
- Use claims that specify administration to treat a designated disease or condition.
Claim Examples (Hypothetical Based on Patent Norms):
- "A pharmaceutical composition comprising [active compound] in a therapeutically effective amount, wherein the composition exhibits a release profile of X hours."
- "A process for preparing the composition, involving mixing steps at temperature Y with solvent Z."
Note: Exact claims are accessible via INPI’s official database or legal document repositories and would specify the scope precisely.
What Does the Patent Landscape Look Like in Brazil for Similar Drugs?
The patent landscape surrounding BR112017010166 includes patents filed by:
- Multinational pharmaceutical companies with existing patents in Brazil.
- Local companies developing similar formulations.
- Basic patents on the core active ingredient, with newer patents covering specific formulations or uses.
Patent Families and Overlapping Rights
- Similar patents often exist in international families, especially within the Patent Cooperation Treaty (PCT) filings, with extensions into the Brazilian market.
- Existing patents focus on the active molecule structure, often with broader claims.
- Subsequent patents cover formulation-specific innovations, such as controlled-release systems.
Key Competitors and Patent Holders
- Global pharma firms like Pfizer, Novartis, and Roche maintain patent families relevant to the therapeutic class.
- Domestic companies frequently file for local protection, especially for formulations or process improvements.
Recent Filing Trends
- Late-stage patent filings (from 2015 onward) increasingly target specific formulations, delivery systems, or combination therapies.
- Some filings focus on formulations suited for pediatric or geriatric populations.
Patent Term and Market Entry Implications
- The patent’s expiration is typically expected around 2037-2038 if filed in 2017, considering Brazil’s 20-year maximum term retained from the priority date.
- Patent challenges or licensing negotiations could influence market exclusivity.
Key Competitive and Legal Considerations
- The scope of claims determines enforceability and potential for patent infringement litigation.
- Overlaps with existing patents can lead to invalidation or licensing negotiations.
- Brazilian patent law emphasizes inventive step and novelty; prior art searches are vital for new filings.
Key Takeaways
- Patent BR112017010166 includes formulation and process claims focused on a specific therapeutic application.
- Its scope restricts third-party manufacturing, use, or sale within Brazil for two decades post-grant.
- The landscape is characterized by overlapping patents, with multinational firms holding broad core molecule patents and local entities filing for incremental innovations.
- Market entry depends on navigating this patent space, considering potential overlaps and expiration timelines.
- Enforceability hinges on the precise wording of claims and any prior art challenges.
FAQs
-
What is the main protected subject matter of Patent BR112017010166?
It covers a specific pharmaceutical composition or process involving a particular active ingredient, targeting a defined medical condition.
-
How long does patent protection last in Brazil?
Typically 20 years from the filing date, provided maintenance fees are paid.
-
What is the significance of related patents in the same therapeutic area?
They can create freedom-to-operate issues, requiring legal analysis to avoid infringement and identify licensing opportunities.
-
Can this patent be challenged or invalidated?
Yes, through legal procedures based on lack of novelty, inventive step, or subject matter exclusions.
-
How does Brazil’s patent law influence drug patent strategies?
It emphasizes novelty and inventive step; patent drafting must clearly delineate claims to avoid overlapping prior art.
References
- Instituto Nacional da Propriedade Industrial (INPI). Patent database. Accessed March 2023.
- WIPO. Patent Landscaping Reports. Brazil Patent Context. 2022.
- World Intellectual Property Organization. Patent Law of Brazil, 2021.
